Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07254208
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
Sponsor: Precision BioSciences, Inc.
View on ClinicalTrials.gov
Summary
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Official title: A Long-term Observational Study in Participants Who Have Received PBGENE-HBV, an In Vivo Gene Editing Investigational Product, in a Prior Clinical Study
Key Details
Gender
All
Age Range
19 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
45
Start Date
2025-12-25
Completion Date
2040-06
Last Updated
2025-11-28
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
PBGENE-HBV
PBGENE-HBV is the investigational product administered in the parent study. This LTFU study is non-interventional; no investigational product given.